Publications by authors named "Emily Piccione"

Claim this Profile
L
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.
Stephen J Schuster, Ling-Yuh Huw, Christopher R Bolen, Victor Maximov, Andrew G Polson, Emily C Piccione

Blood· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies.
Gabrielle Leclercq-Cohen, Nathalie Steinhoff, Llucia Albertí Servera, Sina Nassiri, Sabrina Danilin, Emily Piccione

Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study.
Lihua E Budde, Sarit Assouline, Laurie H Sehn, Stephen J Schuster, Sung-Soo Yoon, Emily C Piccione

J Clin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma.
Ann-Marie E Bröske, Koorosh Korfi, Anton Belousov, Sabine Wilson, Chia-Huey Ooi, Emily C Piccione

Blood Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Feeding Tube-Dependent Children With Oral Aversion in an Intensive Interdisciplinary Treatment Program.
Nancy F Bandstra, Parker L Huston, Kate Zvonek, Carly Heinz, Emily Piccione

J Speech Lang Hear Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical Models.
Stephen B Willingham, Po Y Ho, Andrew Hotson, Craig Hill, Emily C Piccione

Cancer Immunol Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
Emily C Piccione, Silvia Juarez, Serena Tseng, Jie Liu, Melissa Stafford

Clin Cancer Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells.
Emily C Piccione, Silvia Juarez, Jie Liu, Serena Tseng, Christine E Ryan

MAbs· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.
Johan Nilvebrant, D Cameron Dunlop, Aroop Sircar, Thierry Wurch, Emilia Falkowska, Emily C Piccione

MAbs· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis